CRP and temporal arteritis: Traditionally, the GCA evaluation was based on the clinical signs with monitoring of biological inflammatory markers such as erythrocyte sedimentation rate or C-reactive protein (CRP), but with the use of interleukin-6 receptor blockers, these biological parameters are becoming less informative.